0001181431-14-034087.txt : 20141008
0001181431-14-034087.hdr.sgml : 20141008
20141008201401
ACCESSION NUMBER: 0001181431-14-034087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141006
FILED AS OF DATE: 20141008
DATE AS OF CHANGE: 20141008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORGANOVO HOLDINGS, INC.
CENTRAL INDEX KEY: 0001497253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 271488943
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 6275 NANCY RIDGE DRIVE
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-9994
MAIL ADDRESS:
STREET 1: 6275 NANCY RIDGE DRIVE
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: REAL ESTATE RESTORATION & RENTAL, INC.
DATE OF NAME CHANGE: 20100722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Presnell Sharon Collins
CENTRAL INDEX KEY: 0001536585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35996
FILM NUMBER: 141149073
MAIL ADDRESS:
STREET 1: 6275 NANCY RIDGE DRIVE, SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
rrd417337.xml
X0306
4
2014-10-06
0
0001497253
ORGANOVO HOLDINGS, INC.
ONVO
0001536585
Presnell Sharon Collins
6275 NANCY RIDGE DRIVE, SUITE 110
SAN DIEGO
CA
92121
0
1
0
0
EVP, Research & Dev & CTO
Common Stock
2014-10-06
4
S
0
50000
6.1095
D
24064
D
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $6.025 to $6.35 The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This number does not include 1,021,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,045,256 shares of common stock.
/s/ Sharon Collins Presnell
2014-10-08